Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HRS-7058 combined with antitumor therapies in advanced solid tumors
CTR20251267Phase 2Active
- Sponsor
- Shandong Sende
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7058 in Nonhematologic neoplasms, sponsored by Shandong Sende. Started Apr 2025; status: active.
02
Drugs
HRS-7058
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20251267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251267.